ERA Media Release - Mr Helal Alalawi

The ERA Stewards opened an inquiry on Thursday 3rd June 2021, into the notification by the Dubai Equine Forensic Unit (EFU) that the prohibited substance Diisopropylamine had been detected in the pre-race urine sample taken from BEDOUINS BOY (IRE), before it raced in Race 1 “Emirates Holidays Maiden” over 1900 metres at Meydan Racecourse on Thursday 5th November 2020.

Evidence was taken from Mr. Helal Alalawi (Trainer of BEDOUINS BOY (IRE)), Dr. Kieran Finn (ERA Regulatory Veterinarian) and Dr. Michael Subhahar (Chief Analyst – EFU). The following matters were established during the inquiry;
1. On Monday 16th November 2020, the ERA Stewards were advised of the irregularity to Diisopropylamine in respect to the pre-race urine sample taken from BEDOUINS BOY (IRE).
2. On Friday 20th November 2020, Mr. H Alalawi was notified of the irregularity in the sample taken from BEDOUINS BOY (IRE) via an official stable visit at his National Stables.
3. During the stable visit, Mr. H Alalawi advised that he wished to exercise his right to have the reserve portion of the sample analysed by another accredited racing laboratory in accordance with ERA Rule 95D(ii).
4. On Friday 15th January 2021, the ERA Stewards received confirmation from the LGC Laboratory in the UK, that the presence of Diisopropylamine was detected in the “B” urine sample from BEDOUINS BOY (IRE).
5. Evidence was tendered by Dr. K Finn that Diisopropylamine is considered to be a therapeutic substance that is used to aid horses that have “tied up”. Studies have shown that it could have diuretic effects and assist in preventing exercise-induced pulmonary hemorrhage (EIPH) in a horse. Further if present in a race-day sample it is considered to be a prohibited substance under the ERA Rules of Racing. Although the ERA do not publish a recommended withdrawal time for Diisopropylamine, if requested it would be recommended to allow 3 clear days before racing.
6. Evidence was tendered by Dr. M Subhahar that the sample provide by BEDOUINS BOY (IRE) returned medium levels of Diisopropylamine. Further the substance is excreted rapidly and has a short detection time in both plasma and urine.
7. Mr. H Alalawi advised that he is unaware how Diisopropylamine came to be in BEDOUINS BOY’s (IRE) race-day sample, however noted that the substance is present in his stable in a product called “Tridenosen by Nature Vet”. A horse called SNIFTER (IRE) had been treated with the product on Sunday 1st November 2020, the same day BEDOUINS BOY (IRE) received routine vitamin injections. Further, initial research by the stable had shown that Diisopropylamine could be used in a herbicide that is used to help grow hay in the local area. He added that the stable sources hay from local farmers.

Trainer Mr. H Alalawi pleaded guilty to a charge under the provisions of ERA Rule 95AAA 2, in that he presented BEDOUINS BOY (IRE) to race in Race 1 “Emirates Holidays Maiden” over 1900 metres at Meydan Racecourse on Thursday 5th November 2021, which was subsequently found, upon analysis of a pre-race urine sample, to have had Diisopropylamine administered to it, a prohibited substance under the ERA Rules of Racing.

In determining the appropriate penalty in this case, the Stewards considered a number of factors including:
• The circumstances of the offence;
• The nature of the prohibited substance detected, that being a therapeutic substance;
• General and specific deterrence;
• The integrity and image of racing in the UAE;
• Mr. H Alalawi’s and co-operation throughout the inquiry;
• Mr. H Alalawi’s guilty plea and record in relation to the prohibited substance rules (see below).

Mr. H Alalawi was fined the sum of AED 40,000.

Pursuant to ERA 86(ii), BEDOUINS BOY (IRE) was disqualified from sixth (6th) place in Race 1, “Emirates Holidays Maiden” over 1900 metres at Meydan Racecourse on Thursday 5th November 2020 and the placings were adjusted accordingly.

Mr. H Alalawi was advised of his rights of appeal.

Mr. H Alalawi’s record in relation to prohibited substance:
• 7th March 2015 was fined AED 30,000 for pleading guilty to presenting SAFINA GHANTOOT (AE) to the races with the prohibited substance Diphenhydramine.
• 7th March 2015 was fined AED 30,000 for pleading guilty to presenting AHMADANI (AE) to the races with the prohibited substance Diphenhydramine.
• 16th January 2019 was fined AED 50,000 for pleading guilty to presenting MARGHAM DUBAI (FR) to the races with the prohibited substance Total Carbon Dioxide (TCO2).

Relevant Rules:
ERA 86(ii) – Where any declared runner has been the subject of an examination under the Rules 8(vi) and or (vii) and has been found to have received a Prohibited Substances, the Horse shall be disqualified from the Race and from other Races as the ERA determines.

ERA Rule 95AAA 2 – Any Trainer or other Person in charge of a Horse, which is presented to Race or perform a Test, or has Raced or performed a Test which is found (upon analysis) to have had administered to it a Prohibited Substance, shall be liable to a Penalty.

ERA Rules 95D(ii) – Upon the detection by an Accredited Racing Laboratory of a Prohibited Substance in the Sample from a Horse, such laboratory shall notify its finding to the Stewards, who shall then notify the Trainer of the Horse of such finding and give him the option to have the reserve portion of the Sample Tested at another ERA-approved Accredited Racing Laboratory. The Trainer will have 3 days to notify the Stewards of such requirement. A refusal by the Trainer to Test the reserve portion of the Sample shall not prevent the Stewards from having the reserve portion of the Sample Tested.

Stewards Panel:
• Mr. Sam Shinsky (Chairman), Mr. Taylor Wilson and Mr. Jason Coetzee.